2/18: Drug Syndromes Flashcards

1
Q

Serotonin syndrome + epidemiology

A

newborns to elderly, ppl who have overdosed on SSRIs (single SSRI dose can produce the syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Serotonin syndrome + precipitating factors

A

concurrent CYP2D6 and 3A4 inhibitors, withdrawal of concurrent drug tx; agonism of 5-HT2a receptors contribute substantially to the clinical condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

serotonergic neurons in the CNS

A

midline raphe nuclei: brainstem from midbrain –> medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

serotonergic neurons in the CNS: rostral end of the raphe nuclei

A

assists in regulation of wakefulness, affective behavior, food intake thermoregulation, migraine, emesis, and sex behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

serotonergic neurons in the CNS: raphe in the lower pons and medulla

A

participate in regulation of nociception and motor tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

peripheral serotonergic neurons in the CNS

A

assist in regulation of vascular tone and GI motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

spectrum of findings in serotonin syndrome

A

from mild –> life-threatening:

akathisia, tremor, AMS, clonus (inducible–> sustained), muscular hypertonicity), hyperthermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

management of serotonin syndrome

A
  • discontinue use of all potential precipitating drugs
  • provide supportive management
  • control agitation
  • admin serotonin antagonist (cyproheptadine)
  • control autonomic instability
  • control hyperthermia
  • reassess the need to resume the use of the serotonergic agent once the sx have resolved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lithium

A

used in the tx of bipolar disorder; reported to inc serotonin metabolites in the CSF and my interact PD with SSRIs, resulting in serotonin syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

drugs assoc with serotonin syndrome: SSRIs

A

sertraline, fluozetine, fluvoamine, paroxetine, citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

drugs assoc with serotonin syndrome: antidepressants

A

trazodone, nefazodone, busipirone, clomipramine, venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drugs assoc with serotonin syndrome: MAOIs

A

phenelzine, isocarboxazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drugs assoc with serotonin syndrome: AEDs

A

valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

drugs assoc with serotonin syndrome: analgesics

A

meperidinem fentanyl, tramadol, pentazocine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

drugs assoc with serotonin syndrome: antiemetics

A

ondansetron, graniestron, metoclopramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drugs assoc with serotonin syndrome: anti migraine drugs

A

sumatriptans

17
Q

drugs assoc with serotonin syndrome: dietary supplements and herbal products

A

tryptophan, st. john’s wort, ginseng

18
Q

neuroleptic malignant syndrome: MOA + sx

A

blockade of D2 receptors in hypothalamus –> HYPERTHERMIA
blockade of inhibitory actions of dopamine on the SNS –> ANS dysfx
Blockade of nigrostriatal dopamine –> inc muscle rigidity/tremor via extrapyramidal pathways (possible direct muscle toxx via an inc in Ca2+ release from the SR)

19
Q

MC RF for NMS

A

high-dose and high-potency antipsychotic agents (haloperidol»>clozapine, but both), during rapid dose escalation, and with depot forms (IM) of drug release

20
Q

other RF for NMS

A

concomitant use of predisposing drugs (anti-depressants, anticholinergics, lithium), w/drawal of anti-Parkinsonian agents, previous hx of NMS, inc ambient temp or dehydration, catatonia or agitation, history of affective disorders or physical disorders of brain that cause a dec in mental fx

21
Q

management of NMS

A

withdraw causative drug and institute supportive care

22
Q

management of NMS: avoid the following Cx

A

rhabdomyolysis, renal and respiratory failure, recurrence

23
Q

management of NMS: common drug approaches

A

1) dopamine agonists: bromocriptine&raquo_space; amantadine
2) dantrolene: sk.mm. relaxant (also used to treat malignant hyperthermia)
3) lorazepam: reduce psychosis, agitation and anxiety; act as an anticonvulsant

24
Q

management of malignant hyperthermia

A

admin dantrolene IV (to restore IC management of Ca levels), correct metabolic acidosis, monitor serum K+ (admin insulin + glucose + CaCl or gluconate + IV lidocaine for arrhythmia), cool body to <38˚C, maintain urinary output (cold fluids, furosemide and mannitol, if needed)

25
malignant hyperthermia
uncontrolled release of Ca from the SR, leading the the sk.mm. contraction and to stimulation of intermediary metabolism --> metabolic acidosis *assoc MC with the use of volatile anesthetics and the short-acting neuromuscular blocking drug succinylcholine
26
anticholinergic "poisoning"
gives rise to dec PaNA activity --> conseq CV ∆ due to unimpeded SNS stim
27
management of anticholinergic "poisoning"
hyperthermia and agitation: tx with cooling and BNZs
28
when is physostigmine given for anticholinergic poisoning
pt with severe "self-harming" psychosis or hemodynamic dysfx 2˚ to tachydysrhythmias; can access BBB *not given bc of toxicities: seizures, bradyasystole; contra with TCA overdose bc of seizures